HomeAgenda

AdvanSentinel Inc.

Company (SME/startup) / 中小企業・スタートアップ

Osaka, Japan
36 profile visits

About

AdvanSentinel is a joint venture of Shionogi and Shimadzu that develops advanced solutions for wastewater-based epidemiology (WBE) and environmental DNA (eDNA) monitoring. Its core technology, QuickConc™, enables highly sensitive nucleic acid concentration from diverse samples (wastewater, urine, CSF, etc.), supporting early detection of pathogens such as SARS-CoV-2, RSV, and tuberculosis, as well as biodiversity surveillance.

The company combines analytical instrumentation and pharmaceutical expertise to deliver:

  • High-sensitivity pathogen detection (≥30× enrichment, LoD ≤50 copies/mL)

  • Applications in infectious disease surveillance, biodiversity monitoring, and clinical diagnostics

  • Global collaborations with research institutes, NGOs, and diagnostic partners

Business Type / 業種

R&D / 研究開発CRO (Preclinical) / 開発業務受託(非臨床)Reagents / 試薬提供Others / その他

Disease Area / 疾患領域

Infectious diseases / 感染症

Business Domain / 分野

Others /その他

Modalities / モダリティ

Others /その他

Additional questions

Researched company/organisation type / マッチングご希望企業・機関のタイプ

Companies and Academia etc. (Joint research and development purpose) / 企業やアカデミア等(共同での研究、開発を目的)Companies and Entities (Providing your services or technology to your clients) / 技術・サービス(研究、開発、製造等の提供を目的)Consultants, Agents, etc. (Supporting overseas business development) /コンサルタント、代理店等(海外での事業展開支援などを目的)

Researched disease area / マッチングご希望の疾患領域

Infectious diseases / 感染症

Researched Modality / マッチングご希望のモダリティ

Others / その他

Researched Technologies / マッチングご希望の技術

Others /その他